The association of aplasia cutis congenita with therapy of maternal thyroid disease

Pediatr Dermatol. 1986 Sep;3(4):327-30. doi: 10.1111/j.1525-1470.1986.tb00534.x.

Abstract

Aplasia cutis congenita, the localized absence of skin at birth, usually is an isolated scalp defect. We examined an infant with aplasia cutis congenita associated with maternal Grave's disease and the use of methimazole during pregnancy. This association was reported twice before. It has certain implications with respect to therapy of pregnant hyperthyroid women.

Publication types

  • Case Reports

MeSH terms

  • Abnormalities, Drug-Induced / etiology*
  • Adult
  • Female
  • Graves Disease / drug therapy*
  • Humans
  • Infant, Newborn
  • Male
  • Methimazole / adverse effects*
  • Methimazole / therapeutic use
  • Pregnancy
  • Pregnancy Complications / drug therapy*
  • Propylthiouracil / therapeutic use
  • Skin Abnormalities*

Substances

  • Methimazole
  • Propylthiouracil